CONFLUENCE LIFE SCIENCES
CLS is a drug discovery company focusing on rational drug design to discover and develop mechanistically novel kinase inhibitors for use in both human and animal health care. CLS’s kinase inhibitors target key signal transduction enzymes involved in the regulation of cancer growth and survival, or in the modulation of chronic inflammation. Unlike many other kinase inhibitor programs, however, CLS is targeting novel binding sites (on kinase targets that have proved challenging) as well as pre... viously “un-drugged” kinases. Driving CLS success in this effort is a team of world-class experts with extensive Pharma experience in kinase inhibitor discovery and development. CLS provides this team with the opportunity to pursue strategies and targets outside Pharma’s traditional focus. In addition, scientific and business collaborations are being established to enable the success of the business. The strategy is to develop and maintain a program pipeline: discover, develop, partner, repeat.
CONFLUENCE LIFE SCIENCES
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2010-01-01
Address:
St Louis, Missouri, United States
Country:
United States
Website Url:
http://www.confluencelifesciences.com
Total Employee:
11+
Status:
Active
Contact:
(314) 932-4032
Email Addresses:
[email protected]
Total Funding:
13.7 M USD
Technology used in webpage:
SPF Apple Mobile Web Clips Icon OpenResty Network Solutions DNS Mimecast Network Solutions
Current Advisors List
Current Employees Featured
Founder
Investors List
Epidarex Capital
Epidarex Capital investment in Series B - Confluence Life Sciences
St. Louis Arch Angels
St. Louis Arch Angels investment in Series B - Confluence Life Sciences
Missouri Technology Corporation
Missouri Technology Corporation investment in Series B - Confluence Life Sciences
DFJ Mercury
DFJ Mercury investment in Series B - Confluence Life Sciences
BioGenerator
BioGenerator investment in Series B - Confluence Life Sciences
Epidarex Capital
Epidarex Capital investment in Series A - Confluence Life Sciences
DFJ Mercury
DFJ Mercury investment in Series A - Confluence Life Sciences
BioGenerator
BioGenerator investment in Series A - Confluence Life Sciences
Helix Fund
Helix Fund investment in Series A - Confluence Life Sciences
DFJ Mercury
DFJ Mercury investment in Series A - Confluence Life Sciences
Official Site Inspections
http://www.confluencelifesciences.com
- Host name: vux.netsolhost.com
- IP address: 206.188.192.194
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "Confluence Life Sciences"
Confluence Life Sciences - 2025 Company Profile - Tracxn
Confluence Life Sciences is an acquired company based in St. Louis (United States), founded in 2010 by Joseph Monahan. It operates as a Kinase drugs for cancer, autoimmune and …See details»
Confluence Life Sciences, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Confluence Life Sciences, Inc. of Saint Louis, MO. Get the latest business insights from Dun & Bradstreet.See details»
Confluence Life Sciences - Products, Competitors, Financials, …
Headquarters Location. 4320 Forest Park Avenue Suite 303. St. Louis, Missouri, 63108, United States. 314-932-4032See details»
Confluence Life Sciences - Ownership and Business Overview
Aug 8, 2017 Confluence Life Sciences, Inc. is a privately held biotechnology company focused on the discovery and development of kinase inhibitors to treat inflammatory and immunological …See details»
Confluence Life Sciences LLC - Company Profile and News
Confluence Life Sciences, Inc. (CLS) focuses on drug design and discovery. The Company specializes in mechanistically novel inhibitors, targeting transduction enzymes involved in the …See details»
Confluence Life Sciences - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Seed Round - Confluence …See details»
BioGenerator Company Confluence Acquired by Aclaris
Confluence Life Sciences was BioGenerator’s first lab tenant and continues to carry out its research there under the leadership of Joe Monahan and Walter Smith, former Pfizer …See details»
Confluence Life Sciences - VentureRadar
Confluence Life Sciences, Inc. is a technology-based company focusing on rational drug design to identify proprietary, mechanistically novel drugs. Confluence has assembled a team of world …See details»
Confluence Life Sciences - News & Media - BioGenerator
Confluence Life Sciences. Overview. Confluence, now publicly traded Aclaris Therapeutics, is a clinical stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with …See details»
Epidarex Capital portfolio company, Confluence Life Sciences, …
Confluence also operates a profitable Contract Research Organization whose clients includes both large pharmaceutical and early-stage, venture backed companies. Epidarex joined …See details»
Confluence Life Sciences - Golden
Confluence Life Sciences. A company dedicated to drug designs to develop kinase inhibitors for healthcare of human and animals. Overview Structured Data Issues Contributors Activity. …See details»
Confluence Life Sciences - Contacts, Employees, Board
Organization. Confluence Life Sciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of …See details»
Confluence Life Sciences - CB Insights
Explore {Confluence Life Sciences's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Confluence Life …See details»
Confluence Life Sciences Venture Capital and Private Equity …
Confluence Life Sciences. 4320 Forest Park Ave., Suite 303. St. Louis, MO 63108. Phone: 314-932-4032. www.confluencelifesciences.com. Confluence Life Sciences is a drug discovery and …See details»
BioGenerator-Backed Confluence Life Sciences Achieves ... - BioSTL
Confluence Life Sciences was BioGenerator’s first lab tenant and continues to carry out its research there under the leadership of Joe Monahan and Walter Smith, former Pfizer …See details»
Pharmaceutical company acquires St. Louis cancer drug startup for …
Aug 8, 2017 A pharmaceutical company near Philadelphia has acquired Confluence Life Sciences, a St. Louis-based startup developing drugs to treat cancer, for $100 million. …See details»
Confluence Life Sciences - Crunchbase
Confluence Life Sciences and Novellus both operate in the biotechnology sector. Confluence Life Sciences focuses on rational drug designs for kinase inhibitors in human and animal …See details»
Confluence Life Sciences | CipherBio
Explore Confluence Life Sciences's investment information, scientific platforms, therapeutic approaches, indications and more here! Home. PRO Data. Investor Insights. Investors & VCs …See details»
Confluence Life Sciences Raises Capital - vcnewsdaily.com
About Confluence Life Sciences, Inc. Confluence Life Sciences, Inc. is a technology-based company focusing on rational drug design to identify proprietary, mechanistically novel drugs. …See details»
Research Data Analyst 2 at Stanford Medicine
Expertise in the long-term management of large multimodal clinical and quantitative datasets with special emphasis on data cleaning, organization, and quality control. Experience with …See details»